Bayer seeks EMA approval for aflibercept 8 mg for treatment of retinal vein occlusion: Berlin Thursday, April 10, 2025, 16:00 Hrs [IST] Bayer has submitted an application to the E ...

In the European Union and the United Kingdom, aflibercept 8mg (Eylea HD in the US) is currently approved for neovascular ...

Berlin: Bayer has submitted an application to the European Medicines Agency (EMA) seeking approval of aflibercept 8 mg (114.3 ...

Macular disease impacts around one in seven Australians over the age of 50 years and, in some cases, can even lead to ...

Five years from the start of the COVID-19 pandemic, numerous academic studies have shown how the novel coronavirus affects ocular health.

Surrozen will focus its Wnt biology expertise and Wnt signal modulation antibody technologies on its ophthalmology programs including development of new treatment options for retinopathies. Other ...

The NSW Government has announced $180,000 in funding to increase access to treatment and support services for people living with macular disease.

Kodiak Sciences Inc.’s KOD share price has dipped by 10.63%, which has investors questioning if this is right time to buy.

We’re delighted to welcome Leone as Chair of the Board’s Audit Committee,” said David Hallal, Chairman of the Kalaris Board of Directors. “Leone is joining us at the pinnacle of her career as a senior ...

The NSW Government has announced $180,000 in funding to increase access to treatment and support services for people living with macular disease.The ...

Faricimab can reduce the treatment burden in managing macular edema secondary to retinal vein occlusion. Faricimab has sustained efficacy, and can result in gains in best-corrected visual acuity (BCVA ...